Solak Berna, Dikicier Bahar Sevimli, Kara Rabia Oztas, Erdem Teoman
Department of Dermatology, Sakarya University, School of Medicine, Sakarya, Turkey.
Department of Dermatology, Sakarya University Training and Research Hospital, Sakarya, Turkey.
BMJ Case Rep. 2016 Mar 30;2016:bcr2016214563. doi: 10.1136/bcr-2016-214563.
Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) syndrome, also known as drug-induced hypersensitivity syndrome (DHIS), is an acute, potentially life-threatening disease that includes skin rash, fever, haematological abnormalities and multiorgan involvement. Although its aetiopathogenesis is not exactly known, it is thought that inefficient drug detoxification leading to the accumulation of drug reactive metabolites causes autoimmune responses in skin and some internal organs, alters immune responses and induces reactivation of viral infections in people who have genetic predisposition. To the best of our knowledge, only one case of DRESS syndrome has been reported after delivery of the influenza vaccine, but the drug that induced the reaction in that case was sulfasalazine. We report a case of a 64-year-old woman, receiving allopurinol, who developed DRESS syndrome after taking the influenza vaccine.
药物超敏反应伴嗜酸性粒细胞增多和全身症状(DRESS)综合征,也称为药物性超敏反应综合征(DHIS),是一种急性、可能危及生命的疾病,其症状包括皮疹、发热、血液学异常和多器官受累。尽管其发病机制尚不完全清楚,但据认为,药物解毒效率低下导致药物反应性代谢产物积累,从而在皮肤和一些内部器官引发自身免疫反应,改变免疫反应,并在有遗传易感性的人群中诱发病毒感染的重新激活。据我们所知,仅报告过1例在接种流感疫苗后发生DRESS综合征的病例,但该病例中引发反应的药物是柳氮磺胺吡啶。我们报告1例64岁女性,正在服用别嘌醇,在接种流感疫苗后发生了DRESS综合征。